title: Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity.
authors.affiliation: Sylvester Cancer Center, University of Miami, Miami, Florida 33136, USA.
authors.forename: Kavitha
authors.initials: K
authors.lastname: Ramachandran
authors.forename: Heather
authors.initials: H
authors.lastname: Miller
authors.forename: Edna
authors.initials: E
authors.lastname: Gordian
authors.forename: Caio
authors.initials: C
authors.lastname: Rocha-Lima
authors.forename: Rakesh
authors.initials: R
authors.lastname: Singal
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology; D001374:Azacitidine / Q000008:administration & dosage / Q000494:pharmacology; D053468:CARD Signaling Adaptor Proteins; D045744:Cell Line, Tumor; D003598:Cytoskeletal Proteins / Q000096:biosynthesis / Q000235:genetics*; D019175:DNA Methylation; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D000077143:Docetaxel; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D004357:Drug Synergism; D020868:Gene Silencing; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic; D043823:Taxoids / Q000008:administration & dosage / Q000494:pharmacology; D014162:Transfection; D000093542:Gemcitabine
chemical_list: D053468:CARD Signaling Adaptor Proteins; D003598:Cytoskeletal Proteins; C402202:PYCARD protein, human; D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D001374:Azacitidine; D000093542:Gemcitabine